Literature DB >> 18649083

Gammadelta T lymphocytes: a new type of regulatory T cells suppressing murine 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis.

Jörg C Hoffmann1, Nina N Pawlowski, Katja Grollich, Christoph Loddenkemper, Martin Zeitz, Anja A Kühl.   

Abstract

BACKGROUND: The intestinal immune system is continuously challenged by antigen without becoming dysregulated. However, injury of the mucosa by, i.e. dextran sulphate sodium causes severe inflammation in gammadelta T-cell-deficient mice. We therefore asked whether gammadelta T cells have regulatory functions.
MATERIALS AND METHODS: gammadelta T cells were isolated from spleens and mesenteric lymph nodes of C57BL/6 wild-type (wt) mice. Proliferation and cytokine secretion of gammadelta T cells were quantified by [(3)H] thymidine incorporation and ELISA. Additionally, proliferation of carboxyfluorescein diacetate succinimidylester-labelled CD4(+) T cells cocultured with gammadelta T cells was analysed by flow cytometry. Finally, gammadelta T cells from wt or interleukin-10 transgenic (IL-10tg) mice were transferred into congenic mice with 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis.
RESULTS: gammadelta T cells were hyporesponsive to CD3/CD28 stimulation and suppressed CD4(+) T-cell proliferation (up to 66+/-7% suppression) in vitro. Further, the preventive transfer of wt or IL-10tg gammadelta T cells ameliorated TNBS-induced colitis resulting in prolonged survival and reduced histological damage (1.5+/-0.4 and 1.3+/-0.2, respectively vs. 3.8+/-0.3 in untransferred mice, p<0.05). This was accompanied by reduced TNF-alpha and increased IL-10 and TGF-beta secretion from intestinal and splenic lymphocytes.
CONCLUSIONS: Murine gammadelta T cells are a new type of regulatory T cells in vitro and act protective on mouse TNBS-induced colitis in vivo. Future studies have to define the underlying mechanism and to investigate whether gammadelta T cells can be used for immunotherapy of human inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18649083     DOI: 10.1007/s00384-008-0535-8

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  69 in total

1.  gammadelta T cells regulate mucosally induced tolerance in a dose-dependent fashion.

Authors:  K Fujihashi; T Dohi; M N Kweon; J R McGhee; T Koga; M D Cooper; S Tonegawa; H Kiyono
Journal:  Int Immunol       Date:  1999-12       Impact factor: 4.823

Review 2.  Immunoregulation in the tissues by gammadelta T cells.

Authors:  Adrian Hayday; Robert Tigelaar
Journal:  Nat Rev Immunol       Date:  2003-03       Impact factor: 53.106

3.  A regulatory CD4+ T cell subset in the BB rat model of autoimmune diabetes expresses neither CD25 nor Foxp3.

Authors:  Jan-Luuk Hillebrands; Barbara Whalen; Jeroen T J Visser; Jasper Koning; Kenneth D Bishop; Jean Leif; Jan Rozing; John P Mordes; Dale L Greiner; Aldo A Rossini
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

4.  From vanilla to 28 flavors: multiple varieties of T regulatory cells.

Authors:  Ethan M Shevach
Journal:  Immunity       Date:  2006-08       Impact factor: 31.745

5.  Homeostatic regulation of intestinal epithelia by intraepithelial gamma delta T cells.

Authors:  H Komano; Y Fujiura; M Kawaguchi; S Matsumoto; Y Hashimoto; S Obana; P Mombaerts; S Tonegawa; H Yamamoto; S Itohara
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

Review 6.  Regulatory T cells and transplantation tolerance.

Authors:  Shuiping Jiang; Robert I Lechler; Xiao-Shun He; Jie-Fu Huang
Journal:  Hum Immunol       Date:  2006-08-24       Impact factor: 2.850

Review 7.  Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation.

Authors:  Ana Izcue; Janine L Coombes; Fiona Powrie
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

8.  Expression of pro-inflammatory cytokines by TCR alpha beta+ and TCR gamma delta+ T cells in an experimental model of colitis.

Authors:  S J Simpson; G A Holländer; E Mizoguchi; D Allen; A K Bhan; B Wang; C Terhorst
Journal:  Eur J Immunol       Date:  1997-01       Impact factor: 5.532

9.  An important regulatory role for CD4+CD8 alpha alpha T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease.

Authors:  Gobardhan Das; Mathew M Augustine; Jyoti Das; Kim Bottomly; Prabir Ray; Anuradha Ray
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-14       Impact factor: 11.205

10.  Gamma delta T cells provide an early source of interferon gamma in tumor immunity.

Authors:  Yunfei Gao; Wancai Yang; Meng Pan; Eileen Scully; Michael Girardi; Leonard H Augenlicht; Joe Craft; Zhinan Yin
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more
  11 in total

Review 1.  Immunomodulation at epithelial sites by obesity and metabolic disease.

Authors:  Kitty P Cheung; Kristen R Taylor; Julie M Jameson
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

2.  The effect of oral tolerance on the roles of small intestinal intraepithelial lymphocytes in murine colitis induced by dextran sodium sulfate.

Authors:  Yuefang Ye; Min Yue; Xi Jin; Shaohua Chen; Youming Li
Journal:  Int J Colorectal Dis       Date:  2012-01-14       Impact factor: 2.571

3.  Gammadelta T Cells: Unconventional T Cells Involved in IBD Pathogenesis.

Authors:  Ignacio Catalan-Serra; Juan Carlos Andreu-Ballester; Torunn Bruland; Arne Kristian Sandvik
Journal:  Dig Dis Sci       Date:  2018-05-11       Impact factor: 3.199

4.  The protective effect of oral colitis-derived proteins in a murine model of inflammatory bowel disease is associated with an increase in gammadelta T cells in large intestinal mucosa.

Authors:  Yuefang Ye; Xi Jin; Min Yue; Shaohua Chen; Chaohui Yu; Youming Li
Journal:  Int J Colorectal Dis       Date:  2010-06-23       Impact factor: 2.571

5.  Deficit of gammadelta T lymphocytes in the peripheral blood of patients with Crohn's disease.

Authors:  Juan Carlos Andreu-Ballester; Victoria Amigó-García; Ignacio Catalán-Serra; Rafael Gil-Borrás; Ferrán Ballester; Amadeo Almela-Quilis; Monica Millan-Scheiding; Carlos Peñarroja-Otero
Journal:  Dig Dis Sci       Date:  2011-03-05       Impact factor: 3.199

6.  Small intestine CD11c+ CD8+ T cells suppress CD4+ T cell-induced immune colitis.

Authors:  Daisuke Fujiwara; Ling Chen; Bo Wei; Jonathan Braun
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-24       Impact factor: 4.052

7.  A guide to histomorphological evaluation of intestinal inflammation in mouse models.

Authors:  Ulrike Erben; Christoph Loddenkemper; Katja Doerfel; Simone Spieckermann; Dirk Haller; Markus M Heimesaat; Martin Zeitz; Britta Siegmund; Anja A Kühl
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

8.  Preventive Anti-CD2 Treatment does not Impair Parasite Control in a Murine Toxoplasmosis Model.

Authors:  U Erben; N N Pawlowski; M M Heimesaat; C Loddenkemper; K Doerfel; S Spieckermann; B Siegmund; A A Kühl
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-11-12

9.  Immunophenotype of Peripheral Blood Lymphocytes in Dogs with Inflammatory Bowel Disease.

Authors:  A Galler; B C Rütgen; E Haas; A Saalmüller; R A Hirt; W Gerner; I Schwendenwein; B Richter; J G Thalhammer; N Luckschander-Zeller
Journal:  J Vet Intern Med       Date:  2017-09-01       Impact factor: 3.333

10.  Sentinels at the frontline: the role of intraepithelial lymphocytes in inflammatory bowel disease.

Authors:  Madeleine D Hu; Karen L Edelblum
Journal:  Curr Pharmacol Rep       Date:  2017-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.